Treatment of Patients With Blepharitis and Facial Rosacea
Public ClinicalTrials.gov record NCT00560703. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the safety and efficacy of sub-antimicrobial dose COL-101 in the treatment of patients who have both blepharitis and facial rosacea
Study identification
- NCT ID
- NCT00560703
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2007
- Primary completion
- Apr 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Feb 17, 2021
2007 – 2009
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pleasant Valley Ophthalmology | Little Rock | Arkansas | 72212 | — |
| Warren Scherer, MD | Naples | Florida | 34103 | — |
| Kentucky Lions Eye Center | Louisville | Kentucky | 40202 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Marguerite McDonald, MD | Lynbrook | New York | 11563 | — |
| Dean McGee Eye Institute | Oklahoma City | Oklahoma | 73104 | — |
| Anita Nevyas-Wallace, MD | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Tanner Clinic | Layton | Utah | 84041 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00560703, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00560703 live on ClinicalTrials.gov.